| Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection KM Fock, P Katelaris, K Sugano, TL Ang, R Hunt, NJ Talley, SK Lam, ... Journal of gastroenterology and hepatology 24 (10), 1587-1600, 2009 | 756 | 2009 |
| Asia‐Pacific consensus on the management of gastroesophageal reflux disease: update KM Fock, NJ Talley, R Fass, KL Goh, P Katelaris, R Hunt, M Hongo, ... Journal of gastroenterology and hepatology 23 (1), 8-22, 2008 | 296 | 2008 |
| Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. CT Loy, LM Irwig, PH Katelaris, NJ Talley American Journal of Gastroenterology (Springer Nature) 91 (6), 1996 | 278 | 1996 |
| Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? GJH Park, BP Lin, MC Ngu, DB Jones, PH Katelaris Journal of gastroenterology and hepatology 15 (4), 386-390, 2000 | 269 | 2000 |
| World gastroenterology organisation global guidelines: GERD global perspective on gastroesophageal reflux disease R Hunt, D Armstrong, P Katelaris, M Afihene, A Bane, S Bhatia, MH Chen, ... Journal of clinical gastroenterology 51 (6), 467-478, 2017 | 262 | 2017 |
| CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement PG Gibson, AB Chang, NJ Glasgow, PW Holmes, P Katelaris, AS Kemp, ... Medical Journal of Australia 192 (5), 265-271, 2010 | 243 | 2010 |
| Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. PH Katelaris, F Seow, BP Lin, J Napoli, MC Ngu, DB Jones Gut 34 (8), 1032-1037, 1993 | 231 | 1993 |
| Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review BA Adelstein, P Macaskill, SF Chan, PH Katelaris, L Irwig BMC gastroenterology 11, 1-10, 2011 | 230 | 2011 |
| Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus KM Fock, N Talley, KL Goh, K Sugano, P Katelaris, G Holtmann, ... Gut 65 (9), 1402-1415, 2016 | 218 | 2016 |
| A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study PH Katelaris, GM Forbes, NJ Talley, B Crotty, FTAPH Pylori, S Group Gastroenterology 123 (6), 1763-1769, 2002 | 216 | 2002 |
| Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views CP Selinger, J Eaden, W Selby, DB Jones, P Katelaris, G Chapman, ... Journal of Crohn's and Colitis 7 (6), e206-e213, 2013 | 205 | 2013 |
| A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study J Labenz, D Armstrong, K Lauritsen, P Katelaris, S Schmidt, K Schütze, ... Alimentary pharmacology & therapeutics 21 (6), 739-746, 2005 | 190 | 2005 |
| Lactobacilli to prevent traveler's diarrhea? PH Katelaris, I Salam, MJG Farthing New England Journal of Medicine 333 (20), 1360-1361, 1995 | 187 | 1995 |
| The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach ZW Zhang, SE Patchett, D Perrett, PH Katelaris, P Domizio, MJG Farthing Gut 43 (3), 322-326, 1998 | 186 | 1998 |
| Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON) JM Scheiman, PJ Devereaux, J Herlitz, PH Katelaris, A Lanas, ... Heart 97 (10), 797-802, 2011 | 178 | 2011 |
| Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea I Salam, P Katelaris, MJG Farthing, S Leigh-Smith The Lancet 344 (8936), 1537-1539, 1994 | 173 | 1994 |
| The Montreal definition and classification of gastroesophageal reflux disease: a global, evidence-based consensus paper N Vakil, SV Van Zanten, P Kahrilas, J Dent, R Jones Zeitschrift Fur Gastroenterologie 45 (11), 1125-1140, 2007 | 166 | 2007 |
| Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection H Mitchell, P Katelaris The Medical Journal of Australia 204 (10), 376-380, 2016 | 127 | 2016 |
| Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease CP Selinger, J Eaden, DB Jones, P Katelaris, G Chapman, C McDonald, ... Inflammatory bowel diseases 19 (10), 2199-2206, 2013 | 123 | 2013 |
| Patients' knowledge of pregnancy‐related issues in inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’) CP Selinger, J Eaden, W Selby, DB Jones, P Katelaris, G Chapman, ... Alimentary pharmacology & therapeutics 36 (1), 57-63, 2012 | 117 | 2012 |
